Cargando…
Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country
INTRODUCTION: In Colombia, the genetic background of the populations was shaped by different levels of admixture between Natives, European, and Africans. Approximately 35.363 patients have diagnosed chronic kidney disease and according to population studies, 10.4% of these patients are Afro-descenda...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935820/ https://www.ncbi.nlm.nih.gov/pubmed/31929905 http://dx.doi.org/10.1155/2019/7076326 |
_version_ | 1783483639847190528 |
---|---|
author | Duran, Carlos E. Ramírez, Alejandro Posada, Juan G. Schweineberg, Johanna Mesa, Liliana Pachajoa, Harry Estacio, Mayra Manzi, Eliana Aros, Vanessa Díaz, Lorena Garcia, Victor H. |
author_facet | Duran, Carlos E. Ramírez, Alejandro Posada, Juan G. Schweineberg, Johanna Mesa, Liliana Pachajoa, Harry Estacio, Mayra Manzi, Eliana Aros, Vanessa Díaz, Lorena Garcia, Victor H. |
author_sort | Duran, Carlos E. |
collection | PubMed |
description | INTRODUCTION: In Colombia, the genetic background of the populations was shaped by different levels of admixture between Natives, European, and Africans. Approximately 35.363 patients have diagnosed chronic kidney disease and according to population studies, 10.4% of these patients are Afro-descendant. We aim to assess the frequency of APOL1 variants G1 and G2 in Afro-descendant patients with ESRD treated at la Fundacion Valle del Lili University Hospital in Cali, Colombia. METHODS: This is an observational cross-sectional study. Afro-descendant patients with ESRD in waitlist or recipients of kidney transplant were evaluated. Clinical data were collected from the electronic medical records. Genotyping was carried out by amplification of the exon 7 of the APOL1 gene. For the identification of risk genotypes, the bioinformatics tool BLAST was used. RESULTS: We enrolled 102 participants. The frequency of APOL1 risk variants was 67.2%, in which 24.5% (n = 25) were G1 heterozygous and 5.8% (n = 6) were G2 heterozygous and 37% of the patients had high-risk status with two alleles in homozygous (G1/G1 = 21 and G2/G2 = 3) or compound heterozygote (G1/G2 = 14) form. |
format | Online Article Text |
id | pubmed-6935820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-69358202020-01-10 Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country Duran, Carlos E. Ramírez, Alejandro Posada, Juan G. Schweineberg, Johanna Mesa, Liliana Pachajoa, Harry Estacio, Mayra Manzi, Eliana Aros, Vanessa Díaz, Lorena Garcia, Victor H. Int J Nephrol Research Article INTRODUCTION: In Colombia, the genetic background of the populations was shaped by different levels of admixture between Natives, European, and Africans. Approximately 35.363 patients have diagnosed chronic kidney disease and according to population studies, 10.4% of these patients are Afro-descendant. We aim to assess the frequency of APOL1 variants G1 and G2 in Afro-descendant patients with ESRD treated at la Fundacion Valle del Lili University Hospital in Cali, Colombia. METHODS: This is an observational cross-sectional study. Afro-descendant patients with ESRD in waitlist or recipients of kidney transplant were evaluated. Clinical data were collected from the electronic medical records. Genotyping was carried out by amplification of the exon 7 of the APOL1 gene. For the identification of risk genotypes, the bioinformatics tool BLAST was used. RESULTS: We enrolled 102 participants. The frequency of APOL1 risk variants was 67.2%, in which 24.5% (n = 25) were G1 heterozygous and 5.8% (n = 6) were G2 heterozygous and 37% of the patients had high-risk status with two alleles in homozygous (G1/G1 = 21 and G2/G2 = 3) or compound heterozygote (G1/G2 = 14) form. Hindawi 2019-12-18 /pmc/articles/PMC6935820/ /pubmed/31929905 http://dx.doi.org/10.1155/2019/7076326 Text en Copyright © 2019 Carlos E. Duran et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Duran, Carlos E. Ramírez, Alejandro Posada, Juan G. Schweineberg, Johanna Mesa, Liliana Pachajoa, Harry Estacio, Mayra Manzi, Eliana Aros, Vanessa Díaz, Lorena Garcia, Victor H. Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title | Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title_full | Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title_fullStr | Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title_full_unstemmed | Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title_short | Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country |
title_sort | prevalence of apol1 risk variants in afro-descendant patients with chronic kidney disease in a latin american country |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935820/ https://www.ncbi.nlm.nih.gov/pubmed/31929905 http://dx.doi.org/10.1155/2019/7076326 |
work_keys_str_mv | AT durancarlose prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT ramirezalejandro prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT posadajuang prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT schweinebergjohanna prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT mesaliliana prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT pachajoaharry prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT estaciomayra prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT manzieliana prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT arosvanessa prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT diazlorena prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry AT garciavictorh prevalenceofapol1riskvariantsinafrodescendantpatientswithchronickidneydiseaseinalatinamericancountry |